Zhang H - Search Results

1

International consensus on the use of tau PET imaging agent ¹⁸F-flortaucipir in Alzheimer's disease.

Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Zhou R, Hou H, Dou X, Jin C, Zuo C, Zhang H; Molecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program. Tian M, et al. Among authors: zhang h. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):895-904. doi: 10.1007/s00259-021-05673-w. Epub 2022 Jan 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 34978595 Free PMC article.

2

Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.

Zhang H, Tian M, Oriuchi N, Higuchi T, Tanada S, Endo K. Zhang H, et al. Eur J Radiol. 2003 Sep;47(3):199-205. doi: 10.1016/s0720-048x(02)00151-1. Eur J Radiol. 2003. PMID: 12927663

3

Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.

Tian M, Zhang H, Nakasone Y, Mogi K, Endo K. Tian M, et al. Among authors: zhang h. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):5-12. doi: 10.1007/s00259-003-1316-9. Epub 2003 Oct 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 14551748 Clinical Trial.

4

Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.

Zhang H, Tian M, Li S, Liu J, Tanada S, Endo K. Zhang H, et al. Cancer Biother Radiopharm. 2003 Oct;18(5):719-26. doi: 10.1089/108497803770418265. Cancer Biother Radiopharm. 2003. PMID: 14629820

5

[(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.

Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M, Kandatsu S, Kamada T, Tsuji H, Suhara T, Suzuki K, Tanada S, Tsujii H. Zhang H, et al. Clin Cancer Res. 2004 Mar 1;10(5):1764-72. doi: 10.1158/1078-0432.ccr-0190-3. Clin Cancer Res. 2004. PMID: 15014030 Clinical Trial.

6

Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.

Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. Tian M, et al. Among authors: zhang h. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. doi: 10.1007/s00259-004-1496-y. Epub 2004 Mar 11. Eur J Nucl Med Mol Imaging. 2004. PMID: 15014903 Clinical Trial.

7

Oncological diagnosis using (11)C-choline-positron emission tomography in comparison with 2-deoxy-2-[(18)F] fluoro-D-glucose-positron emission tomography.

Tian M, Zhang H, Higuchi T, Oriuchi N, Endo K. Tian M, et al. Among authors: zhang h. Mol Imaging Biol. 2004 May-Jun;6(3):172-9. doi: 10.1016/j.mibio.2004.02.003. Mol Imaging Biol. 2004. PMID: 15193251

8

Carbon-11-methionine positron emission tomography imaging of chordoma.

Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T, Kandatsu S, Suzuki K, Tanada S, Tsujii H. Zhang H, et al. Skeletal Radiol. 2004 Sep;33(9):524-30. doi: 10.1007/s00256-004-0815-5. Epub 2004 Jul 28. Skeletal Radiol. 2004. PMID: 15483754

9

Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice.

Tian M, Zhang H, Higuchi T, Oriuchi N, Inoue T, Endo K. Tian M, et al. Among authors: zhang h. Cancer Biother Radiopharm. 2004 Oct;19(5):601-5. doi: 10.1089/cbr.2004.19.601. Cancer Biother Radiopharm. 2004. PMID: 15650452

10

Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.

Tian M, Zhang H, Higuchi T, Oriuchi N, Nakasone Y, Takata K, Nakajima N, Mogi K, Endo K. Tian M, et al. Among authors: zhang h. Ann Nucl Med. 2005 Jun;19(4):335-8. doi: 10.1007/BF02984629. Ann Nucl Med. 2005. PMID: 16097646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119,036 results

Search Page